BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 27163161)

  • 1. A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway.
    Xue H; Yuan G; Guo X; Liu Q; Zhang J; Gao X; Guo X; Xu S; Li T; Shao Q; Yan S; Li G
    Autophagy; 2016 Jul; 12(7):1129-52. PubMed ID: 27163161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CREBRF is a potent tumor suppressor of glioblastoma by blocking hypoxia-induced autophagy via the CREB3/ATG5 pathway.
    Xue H; Zhang J; Guo X; Wang J; Li J; Gao X; Guo X; Li T; Xu S; Zhang P; Liu Q; Li G
    Int J Oncol; 2016 Aug; 49(2):519-28. PubMed ID: 27278737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells.
    Guo X; Xue H; Guo X; Gao X; Xu S; Yan S; Han X; Li T; Shen J; Li G
    Oncotarget; 2015 Dec; 6(39):41620-37. PubMed ID: 26536662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HIF‑1α/miR‑224‑3p/ATG5 axis affects cell mobility and chemosensitivity by regulating hypoxia‑induced protective autophagy in glioblastoma and astrocytoma.
    Huang S; Qi P; Zhang T; Li F; He X
    Oncol Rep; 2019 Mar; 41(3):1759-1768. PubMed ID: 30569180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo.
    Chakrabarti M; Ray SK
    Apoptosis; 2016 Mar; 21(3):312-28. PubMed ID: 26573275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single nucleotide polymorphisms in interleukin-6 attenuates hepatocytes injury in hypoxia/re-oxygenation via STAT3 signal pathway mediated autophagy.
    Tang H; Fang H; Guo W; Cao S; Guo D; Zhang H; Gao J; Zhang S
    Mol Biol Rep; 2021 Feb; 48(2):1687-1695. PubMed ID: 33484391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway.
    Wan G; Xie W; Liu Z; Xu W; Lao Y; Huang N; Cui K; Liao M; He J; Jiang Y; Yang BB; Xu H; Xu N; Zhang Y
    Autophagy; 2014 Jan; 10(1):70-9. PubMed ID: 24262949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B7-H4(B7x)-Mediated Cross-talk between Glioma-Initiating Cells and Macrophages via the IL6/JAK/STAT3 Pathway Lead to Poor Prognosis in Glioma Patients.
    Yao Y; Ye H; Qi Z; Mo L; Yue Q; Baral A; Hoon DSB; Vera JC; Heiss JD; Chen CC; Zhang J; Jin K; Wang Y; Zang X; Mao Y; Zhou L
    Clin Cancer Res; 2016 Jun; 22(11):2778-2790. PubMed ID: 27001312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
    Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
    Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway.
    Zou M; Hu C; You Q; Zhang A; Wang X; Guo Q
    Mol Carcinog; 2015 Nov; 54(11):1363-75. PubMed ID: 25213258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cobalt chloride treatment induces autophagic apoptosis in human glioma cells via a p53-dependent pathway.
    Cheng BC; Chen JT; Yang ST; Chio CC; Liu SH; Chen RM
    Int J Oncol; 2017 Mar; 50(3):964-974. PubMed ID: 28197638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivo.
    Yuan G; Yan SF; Xue H; Zhang P; Sun JT; Li G
    J Biol Chem; 2014 Apr; 289(15):10607-10619. PubMed ID: 24599950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-6/STAT3 Pathway Signaling Drives an Inflammatory Phenotype in Group A Ependymoma.
    Griesinger AM; Josephson RJ; Donson AM; Mulcahy Levy JM; Amani V; Birks DK; Hoffman LM; Furtek SL; Reigan P; Handler MH; Vibhakar R; Foreman NK
    Cancer Immunol Res; 2015 Oct; 3(10):1165-74. PubMed ID: 25968456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma.
    Hu YL; DeLay M; Jahangiri A; Molinaro AM; Rose SD; Carbonell WS; Aghi MK
    Cancer Res; 2012 Apr; 72(7):1773-83. PubMed ID: 22447568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells.
    Chakrabarti M; Klionsky DJ; Ray SK
    PLoS One; 2016; 11(7):e0158537. PubMed ID: 27388765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of STAT3 and hypoxia markers in long-term surviving malignant glioma patients.
    Dvorakova K; Skarkova V; Vitovcova B; Soukup J; Vosmikova H; Pleskacova Z; Skarka A; Bartos MC; Krupa P; Kasparova P; Petera J; Rudolf E
    BMC Cancer; 2024 Apr; 24(1):509. PubMed ID: 38654280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blocking interleukin-6 signaling inhibits cell viability/proliferation, glycolysis, and colony forming activity of human medulloblastoma cells.
    Chen X; Wei J; Li C; Pierson CR; Finlay JL; Lin J
    Int J Oncol; 2018 Feb; 52(2):571-578. PubMed ID: 29207075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells promote glioma cell stemness through TGF-β-NF-κB-IL6-STAT3 signaling.
    Liu S; Zhang C; Wang B; Zhang H; Qin G; Li C; Cao L; Gao Q; Ping Y; Zhang K; Lian J; Zhao Q; Wang D; Zhang Z; Zhao X; Yang L; Huang L; Yang B; Zhang Y
    Cancer Immunol Immunother; 2021 Sep; 70(9):2601-2616. PubMed ID: 33576874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells.
    Notarangelo T; Sisinni L; Trino S; Calice G; Simeon V; Landriscina M
    Cancer Lett; 2018 Oct; 433():147-155. PubMed ID: 29969659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.